Cargando…

The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer

BACKGROUND: The faecal immunochemical test (FIT) is now available to support clinicians in the assessment of patients at low risk of colorectal cancer (CRC) and within the bowel cancer screening programme. AIM: To determine the diagnostic accuracy of FIT for CRC and clinically significant disease in...

Descripción completa

Detalles Bibliográficos
Autores principales: Turvill, James L, Turnock, Daniel, Cottingham, Dan, Haritakis, Monica, Jeffery, Laura, Girdwood, Annabelle, Hearfield, Tom, Mitchell, Alex, Keding, Ada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279659/
https://www.ncbi.nlm.nih.gov/pubmed/33798091
http://dx.doi.org/10.3399/BJGP.2020.1098
_version_ 1783722500422631424
author Turvill, James L
Turnock, Daniel
Cottingham, Dan
Haritakis, Monica
Jeffery, Laura
Girdwood, Annabelle
Hearfield, Tom
Mitchell, Alex
Keding, Ada
author_facet Turvill, James L
Turnock, Daniel
Cottingham, Dan
Haritakis, Monica
Jeffery, Laura
Girdwood, Annabelle
Hearfield, Tom
Mitchell, Alex
Keding, Ada
author_sort Turvill, James L
collection PubMed
description BACKGROUND: The faecal immunochemical test (FIT) is now available to support clinicians in the assessment of patients at low risk of colorectal cancer (CRC) and within the bowel cancer screening programme. AIM: To determine the diagnostic accuracy of FIT for CRC and clinically significant disease in patients referred as they were judged by their GP to fulfil National Institute for Health and Care Excellence guideline 12 (NG12) criteria for suspected CRC. DESIGN AND SETTING: Patients referred from primary care with suspected CRC, meeting NG12 criteria, to 12 secondary care providers in Yorkshire and Humber were asked to complete a FIT before investigation. METHOD: The diagnostic accuracy of FIT based on final diagnosis was evaluated using receiver operating characteristics analysis. This permitted a statistically optimal cut-off value for FIT to be determined based on the maximisation of sensitivity and specificity. Clinicians and patients were blinded to the FIT results. RESULTS: In total, 5040 patients were fully evaluated and CRC was detected in 151 (3.0%). An optimal cut-off value of 19 µg Hb/g faeces for CRC was determined, giving a sensitivity of 85.4% (95% confidence interval [CI] = 78.8% to 90.6%) and specificity of 85.2% (95% CI = 84.1% to 86.2%). The negative predictive value at this cut-off value was 99.5% (95% CI = 99.2% to 99.7%) and the positive predictive value 15.1% (95% CI = 12.8% to 17.7%). Sensitivity and specificity of FIT for CRC and significant premalignant polyps at this cut-off value were 62.9% (95% CI = 57.5% to 68.0%) and 86.4% (95% CI = 85.4% to 87.4%), respectively; and when including all organic enteric disease were 35.7% (95% CI = 32.9% to 38.5%) and 88.6% (95% CI = 87.5% to 89.6%), respectively. CONCLUSION: FIT used in patients fulfilling NG12 criteria should allow for a more personalised CRC risk assessment. FIT should permit effective, patient-centred decision-making to inform the need for, type, and timing of further investigation.
format Online
Article
Text
id pubmed-8279659
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-82796592021-07-21 The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer Turvill, James L Turnock, Daniel Cottingham, Dan Haritakis, Monica Jeffery, Laura Girdwood, Annabelle Hearfield, Tom Mitchell, Alex Keding, Ada Br J Gen Pract Research BACKGROUND: The faecal immunochemical test (FIT) is now available to support clinicians in the assessment of patients at low risk of colorectal cancer (CRC) and within the bowel cancer screening programme. AIM: To determine the diagnostic accuracy of FIT for CRC and clinically significant disease in patients referred as they were judged by their GP to fulfil National Institute for Health and Care Excellence guideline 12 (NG12) criteria for suspected CRC. DESIGN AND SETTING: Patients referred from primary care with suspected CRC, meeting NG12 criteria, to 12 secondary care providers in Yorkshire and Humber were asked to complete a FIT before investigation. METHOD: The diagnostic accuracy of FIT based on final diagnosis was evaluated using receiver operating characteristics analysis. This permitted a statistically optimal cut-off value for FIT to be determined based on the maximisation of sensitivity and specificity. Clinicians and patients were blinded to the FIT results. RESULTS: In total, 5040 patients were fully evaluated and CRC was detected in 151 (3.0%). An optimal cut-off value of 19 µg Hb/g faeces for CRC was determined, giving a sensitivity of 85.4% (95% confidence interval [CI] = 78.8% to 90.6%) and specificity of 85.2% (95% CI = 84.1% to 86.2%). The negative predictive value at this cut-off value was 99.5% (95% CI = 99.2% to 99.7%) and the positive predictive value 15.1% (95% CI = 12.8% to 17.7%). Sensitivity and specificity of FIT for CRC and significant premalignant polyps at this cut-off value were 62.9% (95% CI = 57.5% to 68.0%) and 86.4% (95% CI = 85.4% to 87.4%), respectively; and when including all organic enteric disease were 35.7% (95% CI = 32.9% to 38.5%) and 88.6% (95% CI = 87.5% to 89.6%), respectively. CONCLUSION: FIT used in patients fulfilling NG12 criteria should allow for a more personalised CRC risk assessment. FIT should permit effective, patient-centred decision-making to inform the need for, type, and timing of further investigation. Royal College of General Practitioners 2021-07-13 /pmc/articles/PMC8279659/ /pubmed/33798091 http://dx.doi.org/10.3399/BJGP.2020.1098 Text en © The Authors https://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Research
Turvill, James L
Turnock, Daniel
Cottingham, Dan
Haritakis, Monica
Jeffery, Laura
Girdwood, Annabelle
Hearfield, Tom
Mitchell, Alex
Keding, Ada
The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
title The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
title_full The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
title_fullStr The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
title_full_unstemmed The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
title_short The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
title_sort fast track fit study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279659/
https://www.ncbi.nlm.nih.gov/pubmed/33798091
http://dx.doi.org/10.3399/BJGP.2020.1098
work_keys_str_mv AT turvilljamesl thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT turnockdaniel thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT cottinghamdan thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT haritakismonica thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT jefferylaura thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT girdwoodannabelle thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT hearfieldtom thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT mitchellalex thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT kedingada thefasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT turvilljamesl fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT turnockdaniel fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT cottinghamdan fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT haritakismonica fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT jefferylaura fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT girdwoodannabelle fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT hearfieldtom fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT mitchellalex fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer
AT kedingada fasttrackfitstudydiagnosticaccuracyoffaecalimmunochemicaltestforhaemoglobininpatientswithsuspectedcolorectalcancer